As our in vitro data (figure 1C) suggested that VE-822 might interfere with PD-L1 expression in cancer cells, we tested whether Vox could increase anti-PD-1 immunotherapy efficacy in two CRC-PM models. The gene discussed is CD274; the disease is colorectal carcinoma.